69 results
8-K
EX-99.1
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
for COVID-19 treatment, if authorized, or inventory build that may be required to deliver medicine timely to patients in need.
Research & Development (R … , 2023
Operating expenses:
Research and development(1)
Acquired in-process research and development(2)
Selling, general and administrative
Total
8-K
EX-99.2
IVVD
Invivyd Inc
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
: At-the-market; COGS: cost of goods sold; R&D: Research and development 7
Q&A 8
T H A N K YO U !
8-K
EX-99.1
ti2q5imc8mhb u37f
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
EX-99.1
b2aw30m
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
EX-99.1
9jee7
8 Jan 24
Other Events
7:12am
8-K
EX-99.1
jk3zqu3lu975 gaewz4
3 Jan 24
Other Events
7:06am
424B5
6n3lty 8t
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
6mlhiugywot4
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
EX-99.1
qwy 24d5v1
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
EX-99.1
2g4qmlj5
11 Sep 23
Other Events
7:10am
8-K
EX-99.1
p29eoj1rkemv8kieh81
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am
8-K
EX-99.1
oemsm
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
EX-99.1
7v2 fog3nt
27 Jul 23
Invivyd Announces Appointment of Sara Cotter to Board of Directors
4:06pm
8-K
EX-99.1
ldn tu7o6sy
29 Jun 23
Other Events
7:08am